This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thardin, J F Articles by Pipy, B Search for Related Content PubMed PubMed Citation Articles by Thardin, J F Articles by Pipy, B

 Previous Article  |  Next Article 

Infect Immun. 1993 April; 61(4): 1432-1441

Eicosanoid production by mouse peritoneal macrophages during Toxoplasma gondii penetration: role of parasite and host cell phospholipases.

J F Thardin, C M'Rini, M Beraud, J Vandaele, M F Frisach, M H Bessieres, J P Seguela and B Pipy

Laboratoire de la Signalisation et de la Différenciation des Macrophages, INSERM CJF 9107, Institut Louis Bugnard, Université Paul Sabatier, Toulouse, France.

ABSTRACT

The metabolism of endogenous arachidonic acid by mouse resident peritoneal macrophages infected in vitro with Toxoplasma gondii was studied. Prelabeling of macrophages with [5,6,8,9,11,12,14,15-3H]arachidonic acid and challenge with tachyzoites for 15 min resulted in a high mobilization of free labeled arachidonic acid (178%) in the culture medium. The parasites also triggered the synthesis of 6-keto-prostaglandin F1 alpha (47%), prostaglandin E2 (44%), leukotrienes C4 and D4 (33%) and 5-, 12-hydroxyeicosatetraenoic acids (155%). The study indicated that during the intracellular development phase of the parasites, 6-keto-prostaglandin F1 alpha (38%), prostaglandin E2 (31%) leukotrienes C4 and D4 (15%), hydroxyeicosatetraenoic acids (43%), and free arachidonic acid (110%) were secreted into the culture medium. Pretreatment of tachyzoites with phospholipase A2 inhibitors (4-p-bromophenacyl bromide and quinacrine) and no calcium in the culture medium resulted in inhibition of tachyzoite penetration into the macrophages and a decrease of the arachidonic acid metabolism. The triggering of the arachidonic acid cascade by T. gondii was dependent on the active penetration of the parasites into the macrophages, whereas preincubation of the macrophages with phospholipase A2 inhibitors did not affect penetration or free arachidonic acid release, thereby supporting a role for parasite phospholipase in the penetration process and in arachidonic acid mobilization from macrophage membrane phospholipids. Moreover, treatment of macrophages with phospholipase A2 inhibitors decreased the activities of the cyclooxygenase and lipoxygenase pathways, also suggesting an activation of host cell phospholipase A2 by the parasite.

---

Infect Immun. 1993 April; 61(4): 1432-1441

This article has been cited by other articles:

• Debierre-Grockiego, F., Rabi, K., Schmidt, J., Geyer, H., Geyer, R., Schwarz, R. T. (2007). Fatty Acids Isolated from Toxoplasma gondii Reduce Glycosylphosphatidylinositol-Induced Tumor Necrosis Factor Alpha Production through Inhibition of the NF-{kappa}B Signaling Pathway. Infect. Immun. 75: 2886-2893 [Abstract] [Full Text]  
• Cavailles, P., Sergent, V., Bisanz, C., Papapietro, O., Colacios, C., Mas, M., Subra, J.-F., Lagrange, D., Calise, M., Appolinaire, S., Faraut, T., Druet, P., Saoudi, A., Bessieres, M.-H., Pipy, B., Cesbron-Delauw, M.-F., Fournie, G. J. (2006). The rat Toxo1 locus directs toxoplasmosis outcome and controls parasite proliferation and spreading by macrophage-dependent mechanisms. Proc. Natl. Acad. Sci. USA 103: 744-749 [Abstract] [Full Text]  
• Noverr, M. C., Erb-Downward, J. R., Huffnagle, G. B. (2003). Production of Eicosanoids and Other Oxylipins by Pathogenic Eukaryotic Microbes. Clin. Microbiol. Rev. 16: 517-533 [Abstract] [Full Text]  
• Black, M. W., Boothroyd, J. C. (2000). Lytic Cycle of Toxoplasma gondii. Microbiol. Mol. Biol. Rev. 64: 607-623 [Abstract] [Full Text]  
• Conseil, V., Soête, M., Dubremetz, J. F. (1999). Serine Protease Inhibitors Block Invasion of Host Cells by Toxoplasma gondii. Antimicrob. Agents Chemother. 43: 1358-1361 [Abstract] [Full Text]